# Round 2 — Adversarial Rebuttal — qwen/qwen3-max-thinking

*This reviewer is **Reviewer F** in the anonymised dossier. It was shown all six round-1 reviews and asked to concede, withdraw, rebut, and re-rank. Generated 2026-09-05 07:03 PDT via OpenRouter. Tokens: 19057 in / 1383 out. 28s.*

---

**1. CONCEDED — where another reviewer beat me.**  
Reviewer G demolished my handling of the CPm falsification claim. I rated it “Moderate” based on amino-acid identity alone, but G showed the *functional* test in B3—adding CPm+5′-UTR to the p33-swap virus yields 17/90 vs 16/90 (p = 1.00)—is far stronger evidence that CPm adds nothing. The alignment is secondary; the swap experiment directly tests CPm’s contribution and finds none. I underweighted this because I fixated on the theoretical possibility of RNA-level effects, but the data already rule out a detectable functional role for CPm in this background. G’s point stands: lead with the functional null, not the sequence identity.

**2. WITHDRAWN — my own claims that do not survive.**  
> “p33 swap increases transmission from 1.5% to 17.8% | **Moderate** | Effect size is large, but sample sizes are small (n=66 vs n=90). Fisher exact test yields p ≈ 0.0015 [...] Replication missing.”  

I am dropping the “Moderate” rating and upgrading it to **Strong**. Reviewers A, B, D, E, and G all correctly compute Fisher’s exact p-value as ≈0.0012 (I misremembered it as 0.0015, but that’s immaterial). More importantly, they uniformly agree the non-overlapping CIs (T36: 0.04–7.7%; p33-swap: 10.5–27.3%) and large effect size constitute robust evidence *for a p33-region effect in this background*. My “replication missing” caveat is valid but does not downgrade the strength of the *reported* result—it only limits generalizability. The brief presents this as a single key experiment, and within that frame, the evidence is strong.

**3. REBUTTED — criticisms by others that are wrong.**  
Reviewer D claims: “Step 2 (p33 explains ‘most’ of the gap): Mathematically false. The gap between T36 (1.5%) and T68-1 (44.18%) is 42.68 percentage points. The p33 swap increased transmission to 17.8% (a gain of 16.3 points). p33 explains roughly 38% of the gap, not ‘most’ of it.”  

This fails because it misreads the inference chain. Section C, Step 2 says: “p33 explains most of the gap → p33 swap: 17.8% vs 1.5% baseline.” The “gap” referenced is *not* T68-1 minus T36 (44.18% – 1.5%); it is the *difference created by the swap itself*. The team never claims p33 recovers “most” of T68-1’s absolute rate—they say the p33 substitution accounts for most of the *gain observed in their experiment*. That is descriptively true: adding p33 yields +16.3 points; adding CPm+UTR yields only +1.1 more. So ~94% of the *observed gain in their chimera series* comes from p33 alone. D’s arithmetic is correct but applied to the wrong denominator. This is a misreading, not a factual error—but it leads D to overstate the team’s overreach.

**4. SURVIVING FINDINGS — ranked.**  
1. **K174R is not a supported residue target** (CHECKABLE). T30 and FS577 both encode R174 yet differ 15-fold in transmission (2/127 = 1.57% vs 24.1%). This directly falsifies K174 as necessary or sufficient. Raised by A, B, D, E, F, G.  
2. **The 5.2% “gap” attributed to p61/p65 is unverifiable and likely artifactual** (CHECKABLE). Harper 2016’s 23% lacks denominators; even if real, 23% (CI unknown) vs 17.8% (CI 10.5–27.3%) overlaps heavily. Power to detect 5.2-point difference at n=90 is ~14%. Raised by A, B, D, E, G.  
3. **Transmission differences may reflect source-plant titer, not vector-specific determinants** (JUDGEMENT). p33 is a viroporin affecting membrane stability/virion yield; higher titer could inflate apparent transmission without altering aphid-virion binding. No titer normalization in any assay. Raised by A, B, D, E.  
4. **FS577’s 24.1% transmission rate is unanchored without a denominator** (CHECKABLE). Cannot be compared statistically to other rates. Raised by A, B, D, E, G.  
5. **The inference chain conflates T68-1 vs T36 (29-fold) with FS577 vs T36 (16-fold)** (CHECKABLE). B1 incorrectly states “16-fold difference [...] between high (T68-1) and low (T36)”. Arithmetic: 44.18/1.5 ≈ 29.4. Raised by A, B.

**5. VERDICT AFTER REBUTTAL.**  
My verdict tightens: **Do not proceed with the proposed construct design (p33 K174R + p61/p65 variants) because K174R is contradicted by internal data and p61/p65 rest on an unverified cross-study subtraction—but do proceed with a narrowed plan focused on whole-gene p33 swaps and reciprocal chimeras, pending retrieval of Harper 2016 and Shilts 2026 full texts.** What moved me was Reviewer G’s emphasis on the reciprocal swap as a cheap falsification test and the consensus that K174R is indefensible; I now see the original plan as fundamentally misaligned with the data.
